scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1532-5415.2002.50455.X |
P698 | PubMed publication ID | 12366617 |
P50 | author | Cynthia L. Leibson | Q114081686 |
Jeanine E. Ransom | Q114104525 | ||
Anna N. A. Tosteson | Q110143968 | ||
L. Joseph Melton | Q112619624 | ||
P2093 | author name string | Sherine E Gabriel | |
P2860 | cites work | A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 |
Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes. | Q33949350 | ||
Cerebral vascular accidents in patients over the age of 60. II. Prognosis | Q34241339 | ||
History of the Rochester Epidemiology Project | Q34374377 | ||
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases | Q34439990 | ||
Decline in physical function following hip fracture | Q39235646 | ||
How to predict return to the community after fractured proximal femur in the elderly | Q40793343 | ||
Modeling lifetime nursing home use under assumptions of better health | Q40849644 | ||
The aging of America. Impact on health care costs | Q41192040 | ||
Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation | Q43583991 | ||
Cost-effective treatment strategies for osteoporosis | Q44197505 | ||
Institutionalized patients with hip fractures: characteristics associated with returning to community dwelling. | Q50551510 | ||
Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival. | Q50872047 | ||
Cohort study of risk of institutionalisation after hip fracture. | Q50960032 | ||
Extending Gerontological Research Through Linking Investigators' Studies to Public-Use Datasets | Q57695612 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | disability | Q12131 |
bone fracture | Q68833 | ||
P304 | page(s) | 1644-1650 | |
P577 | publication date | 2002-10-01 | |
P1433 | published in | Journal of the American Geriatrics Society | Q6296094 |
P1476 | title | Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study | |
P478 | volume | 50 |
Q82904019 | "N-active": a new comanaged, orthogeriatric ward: observations and prospects |
Q49849162 | 3-T MR Imaging of Proximal Femur Microarchitecture in Subjects with and without Fragility Fracture and Nonosteoporotic Proximal Femur Bone Mineral Density |
Q39465246 | A Resident-led Initiative Improves Screening and Treatment for Vitamin D Deficiency in Patients with Hip Fractures |
Q44510314 | A cross-sectional study of the prevalence, correlates, and costs of falls in older home care clients 'at risk' for falling |
Q37352516 | A new approach to menopausal therapy: the tissue selective estrogen complex |
Q91286353 | A surrogate mechanostatistical microstructural model to inform whole hip cortical bone remodelling |
Q37750520 | Addressing the age-related needs of osteoporotic patients with strontium ranelate |
Q37436300 | An 8-week Aquatic Exercise Program is Effective at Improving Gait Stability of the Elderly |
Q37672363 | An investigation of the association between omega 3 FA and bone mineral density among older adults: results from the National Health and Nutrition Examination Survey years 2005–2008. |
Q37822779 | Antifracture efficacy of currently available therapies for postmenopausal osteoporosis |
Q39671348 | Antipsychotic Drugs and Risk of Hip Fracture in People Aged 60 and Older in Norway |
Q46803164 | Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis? |
Q43727102 | Association between use of benzodiazepines and risk of fractures: a meta-analysis |
Q51741457 | Association of air particulate pollution with bone loss over time and bone fracture risk: analysis of data from two independent studies. |
Q90138490 | Atrial fibrillation and the risk of subsequent fracture |
Q35229885 | BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS). |
Q36461952 | Bayesian decision analysis for choosing between diagnostic/prognostic prediction procedures |
Q33610208 | Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis |
Q92639976 | Bipolar Hemiarthroplasty of Hip in an Unstable Angina Patient: A Case Report |
Q33702810 | Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives |
Q33851671 | Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project |
Q34680563 | Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer. |
Q36700347 | Chronic Obstructive Pulmonary Disease Increases the Risk of Hip Fracture: A Nationwide Population-Based Cohort Study. |
Q27016636 | Chronic proton pump inihibitor therapy and calcium metabolism |
Q99615002 | Circulating MicroRNAs as Novel Biomarkers for Osteoporosis and Fragility Fracture Risk: Is There a Use in Assessment Risk? |
Q52594742 | Clinical Management of Osteoporotic Fractures. |
Q39106834 | Cohort study evaluating the risk of hip fracture among patients with dementia in Taiwan. |
Q58802680 | Comorbidities, clinical intercurrences, and factors associated with mortality in elderly patients admitted for a hip fracture |
Q64323431 | Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States |
Q37085615 | Cost-effectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight. |
Q46553467 | Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA. |
Q33282322 | Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia |
Q44227480 | Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study |
Q37931985 | Current options for the management of postmenopausal osteoporosis |
Q36696695 | DEXA screening--are we doing too much? |
Q37685432 | Death, debility, and destitution following hip fracture |
Q36683982 | Dementia and hip fractures: development of a pathogenic framework for understanding and studying risk |
Q37810423 | Denosumab for the Management of Postmenopausal Osteoporosis |
Q46891538 | Depressive symptoms and fear of falling in previously community-dwelling older persons recovering from proximal femoral fracture |
Q37199923 | Diagnosis and management of osteoporosis in the older senior |
Q34667487 | Dietary acid load is not associated with lower bone mineral density except in older men |
Q36172126 | Does cognitive/physical screening in an outpatient setting predict institutionalization after hip fracture? |
Q35858255 | Dose-Effectiveness Relationships Determining the Efficacy of Ibandronate for Management of Osteoporosis: A Meta-Analysis |
Q54542698 | Effect of occupational therapy on functional and emotional outcomes after hip fracture treatment: a randomized controlled trial. |
Q41964250 | Effects of Tai Chi on balance and fall prevention in Parkinson's disease: a randomized controlled trial |
Q37001665 | Effects of rabeprazole on bone metabolic disorders in a gastrectomized rat model |
Q46767327 | Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women |
Q33788826 | Emergency Department Pain Management Following Implementation of a Geriatric Hip Fracture Program |
Q39045046 | Epidemiology and Postoperative Outcomes of Atypical Femoral Fractures in Older Adults: A Systematic Review |
Q82723971 | Epidemiology of osteoporosis |
Q35015878 | Evaluation of the effect of a comprehensive multidisciplinary care pathway for hip fractures: design of a controlled study |
Q36620541 | Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate |
Q35120734 | Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures |
Q40032001 | Exposure to medicines among patients admitted for hip fracture and the case-fatality rate at 1 year: a longitudinal study |
Q36406647 | Factors associated with mortality following hip fracture in Japan |
Q37401866 | Family physicians' personal and practice characteristics that are associated with improved utilization of bone mineral density testing and osteoporosis medication prescribing |
Q35949189 | Farnesyl diphosphate synthase: a novel genotype association with bone mineral density in elderly women |
Q37732469 | Feasibility of three-dimensional MRI of proximal femur microarchitecture at 3 tesla using 26 receive elements without and with parallel imaging. |
Q38236887 | Fracture mortality: associations with epidemiology and osteoporosis treatment |
Q35194455 | Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients |
Q58757367 | Fracture risk assessment in home care patients using the FRAX® tool |
Q46068063 | Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates |
Q91810820 | Fragility Fracture Prevention-Implementing a Fracture Liaison Service in a High Volume Orthopedic Hospital |
Q35953426 | Frailty and Short-Term Outcomes in Patients With Hip Fracture |
Q47732600 | Health Risk Perceptions and Exercise in Older Adulthood: An Application of Protection Motivation Theory |
Q53282553 | Health-related quality of life measurements in elderly Canadians with osteoporosis compared to other chronic medical conditions: a population-based study from the Canadian Multicentre Osteoporosis Study (CaMos). |
Q39493451 | High Levels of Geriatric Palliative Care Needs in Hip Fracture Patients Before the Hip Fracture |
Q34599603 | Higher fish intake is associated with a lower risk of hip fractures in Chinese men and women: a matched case-control study |
Q36623119 | Hip fracture and increased short-term but not long-term mortality in healthy older women |
Q33837287 | Hip fracture epidemiological trends, outcomes, and risk factors, 1970-2009 |
Q51916742 | Hip fracture risk among community-dwelling elderly people in the United States: a prospective study of physical, cognitive, and socioeconomic indicators. |
Q26829440 | Hip fractures in a geriatric population - rehabilitation based on patients needs |
Q44612757 | Hip fractures in institutionalized elderly people: incidence rates and excess mortality |
Q46232408 | Hip fractures in the United States: 2008 nationwide emergency department sample |
Q37049150 | Hip structural analysis: a comparison of DXA with CT in postmenopausal Japanese women |
Q24651058 | History of fractures as predictor of subsequent hip and nonhip fractures among older Mexican Americans |
Q48251787 | Home, please: A conjoint analysis of patient preferences after a bad hip fracture |
Q36533644 | Hormone therapy: maximizing the benefits |
Q40126151 | Impact of malnutrition on 12-month mortality following acute hip fracture |
Q33644466 | Improving care after hip fracture: the fracture? Think osteoporosis (FTOP) program |
Q91822207 | In vitro injection of osteoporotic cadaveric femurs with a triphasic calcium-based implant confers immediate biomechanical integrity |
Q41917351 | Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss |
Q50055457 | Incidence Rates of and Mortality after Hip Fracture among German Nursing Home Residents |
Q49322761 | Incidence and mortality of fractures by frailty level over 80 years of age: cohort study using UK electronic health records. |
Q38896852 | Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study. |
Q40551201 | Incident atrial fibrillation and the risk of fracture in the cardiovascular health study |
Q36285963 | Incorporating quality of evidence into decision analytic modeling |
Q45167061 | Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications |
Q94547176 | Individual and joint trajectories of change in bone, lean mass and physical performance in older men |
Q33321341 | Individual nutrition therapy and exercise regime: a controlled trial of injured, vulnerable elderly (INTERACTIVE trial) |
Q42684289 | Initiation of antihypertensive monotherapy and incident fractures among Medicare beneficiaries |
Q36127633 | Interventions to Alleviate Symptoms Related to Breast Cancer Treatments and Areas of Needed Research |
Q35953419 | Is Scheduled Intravenous Acetaminophen Effective in the Pain Management Protocol of Geriatric Hip Fractures? |
Q92101018 | Key Service Improvements After the Introduction of an Integrated Orthogeriatric Service |
Q64106339 | Large cortical bone pores in the tibia are associated with proximal femur strength |
Q33614562 | Linking the Iowa Women's Health Study cohort to Medicare data: linkage results and application to hip fracture. |
Q37919556 | Literature review: using pictographs in discharge instructions for older adults with low-literacy skills |
Q36421367 | Long term health outcomes after injury in working age adults: a systematic review |
Q48951409 | Long-term effects of home rehabilitation after hip fracture - 1-year follow-up of functioning, balance confidence, and health-related quality of life in elderly people |
Q36876802 | Long-term mortality following injury in working-age adults: a systematic review. |
Q41681791 | MORTALITY AND FUNCTION AFTER SURGICALLY-TREATED HIP FRACTURE IN ADULTS YOUNGER THAN AGE 60. |
Q38761009 | MRI assessment of bone structure and microarchitecture. |
Q92356877 | MRI-derived bone porosity index correlates to bone composition and mechanical stiffness |
Q64107628 | Management of Fragility Hip Fractures: Our Institutional Experience |
Q37337113 | Management of osteoporosis in the aging male: focus on zoledronic acid |
Q26824069 | Maximising functional recovery following hip fracture in frail seniors |
Q33503680 | Medial hip neck fracture: influence of pre-operative delay on the quality of outcome. Results of data from the external in-hospital quality assurance within the framework of secondary data analysis |
Q38920718 | Medical management of osteoporosis and the surgeons' role |
Q35886848 | Meta-Analysis of a Complex Network of Non-Pharmacological Interventions: The Example of Femoral Neck Fracture |
Q58433670 | Minimally invasive anterior muscle-sparing versus a transgluteal approach for hemiarthroplasty in femoral neck fractures-a prospective randomised controlled trial including 190 elderly patients |
Q34014211 | Mortality and osteoporotic fractures: is the link causal, and is it modifiable? |
Q36283404 | Municipal resources and patient outcomes through the first year after a hip fracture |
Q36671394 | Myocardial infarction after hip fracture repair: a population-based study |
Q37842737 | New treatment approach for osteopenia |
Q88231775 | Numerical investigation of the effect of bone cement porosity on osteoporotic femoral augmentation |
Q33220023 | On the prognosis of hip fractures. Assessment of mortality after hip fractures by analyzing overlapping segments of longitudinal data |
Q38669033 | OnabotulinumtoxinA Treatment for Overactive Bladder in the Elderly: Practical Points and Future Prospects |
Q58698204 | Optimization the Initial Weights of Artificial Neural Networks via Genetic Algorithm Applied to Hip Bone Fracture Prediction |
Q38126393 | Orthogeriatric care models and outcomes in hip fracture patients: a systematic review and meta-analysis |
Q26738519 | Orthogeriatric care: improving patient outcomes |
Q79299225 | Osteoporosis |
Q26824690 | Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications |
Q38002942 | Osteoporosis and osteopenia: implications for periodontal and implant therapy |
Q46865059 | Osteoporosis in the elderly |
Q56785994 | Osteoporotic hip fractures in non-elderly patients: relevance of associated co-morbidities |
Q38576989 | Osteoporotic hip fractures: 10-year review in a Singaporean hospital |
Q37807918 | Outcome in geriatric fracture patients and how it can be improved |
Q39077620 | Own the Bone, a System-Based Intervention, Improves Osteoporosis Care After Fragility Fractures. |
Q36793560 | Panoramic images of white and black post-menopausal females evidencing carotid calcifications are at high risk of comorbid osteopenia of the femoral neck |
Q33850387 | Patient safety in elderly hip fracture patients: design of a randomised controlled trial |
Q39029467 | Patient-specific Hip Fracture Strength Assessment with Microstructural MR Imaging-based Finite Element Modeling. |
Q30811657 | Patients with femoral or distal forearm fracture in Germany: a prospective observational study on health care situation and outcome |
Q39455613 | Pharmacological treatment of osteoporosis in the oldest old. |
Q34974773 | Physical activity and hip fracture disability: a review |
Q36590218 | Plasma phosphatidylcholine concentrations of polyunsaturated fatty acids are differentially associated with hip bone mineral density and hip fracture in older adults: the Framingham Osteoporosis Study |
Q37448214 | Polyunsaturated fatty acids and their relation with bone and muscle health in adults. |
Q36315408 | Postacute rehabilitation care for hip fracture: who gets the most care? |
Q40392736 | Potential cost-effective use of spine radiographs to detect vertebral deformity and select osteopenic post-menopausal women for amino-bisphosphonate therapy |
Q79184483 | Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy |
Q88636789 | Practical points in the medical treatment of overactive bladder and nocturia in the elderly |
Q53061961 | Pre-discharge home visits by occupational therapists completed for patients following hip fracture. |
Q35186518 | Precision of volumetric assessment of proximal femur microarchitecture from high-resolution 3T MRI. |
Q40975843 | Predictive factors of adverse events after intravesical suburothelial onabotulinumtoxina injections for overactive bladder syndrome-A real-life practice of 290 cases in a single center |
Q35681100 | Predictors of functional outcome following femoral neck fractures treated with an arthroplasty: limitations of the Harris hip score |
Q33914532 | Prevalence and Risk Factors of Osteoporosis Among Jordanian Postmenopausal Women Attending the National Center for Diabetes, Endocrinology and Genetics in Jordan |
Q46381412 | Prevalence of vertebral fracture in elderly men and women with osteopenia |
Q37417515 | Preventing nonvertebral osteoporotic fractures with extended-interval bisphosphonates: regimen selection and clinical application. |
Q38778102 | Prophylactic augmentation of the osteoporotic proximal femur-mission impossible? |
Q40659849 | Prospective study of predictive factors of changes in pain and hip function after hip fracture among the elderly. |
Q30881569 | Protective effect of bisphosphonates on endometrial cancer incidence in data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial |
Q91963630 | Proximal Femur Hounsfield Units on CT Colonoscopy Correlate With Dual-energy X-ray Absorptiometry |
Q40732563 | Proximal femur geometry assessed by hip structural analysis in hip fracture in women |
Q49306564 | Quality of life and psychological consequences in elderly patients after a hip fracture: a review. |
Q37346101 | Quarterly intravenous ibandronate for postmenopausal osteoporosis |
Q53731159 | Radiographic study of the proximal femur morphology of elderly patients with femoral neck fractures: is there a difference among ethnic groups? |
Q37126681 | Recent hospitalization and the risk of hip fracture among older Americans. |
Q48427955 | Recovery of function following a hip fracture in geriatric ambulatory persons living in nursing homes: prospective cohort study |
Q64231756 | Regaining Versus Not Regaining Function Following Hip Fracture-A Descriptive Study |
Q24240347 | Rehabilitation interventions for improving physical and psychosocial functioning after hip fracture in older people |
Q24240428 | Rehabilitation interventions for improving physical and psychosocial functioning after hip fracture in older people |
Q24242170 | Rehabilitation interventions for improving physical and psychosocial functioning after hip fracture in older people |
Q48301823 | Relation between Spongy Bone Density in the Maxilla and Skeletal Bone Density. |
Q61941678 | Relative survival after hospitalisation for hip fracture in older people in New South Wales, Australia |
Q41585378 | Reliability and validity of the Falls Efficacy Scale-International after hip fracture in patients aged ≥ 65 years |
Q58543140 | Residual Disability, Mortality, and Nursing Home Placement after Hip Fracture over Two Decades |
Q34004364 | Rethinking guidelines for VTE risk among nursing home residents: a population-based study merging medical record detail with standardized nursing home assessments. |
Q36430746 | Retrospective evaluation versus population norms for the measurement of baseline health status |
Q53128627 | Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry. |
Q35857544 | Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study |
Q33741249 | Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study |
Q64269246 | Risk of imminent fracture following a previous fracture in a Swedish database study |
Q64977310 | Risk of subsequent fracture after prior fracture among older women. |
Q38033250 | Role of comprehensive geriatric assessment in the management of osteoporotic hip fracture in the elderly: an overview |
Q35026446 | Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management |
Q41137591 | Sedative-hypnotic medicines and falls in community-dwelling older adults: a cost-effectiveness (decision-tree) analysis from a US Medicare perspective |
Q36601333 | Senior Managed Care System for Hip Fracture in the United States |
Q43843406 | Severity of cognitive impairment as a prognostic factor for mortality and functional recovery of geriatric patients with hip fracture |
Q36580612 | Sex-specific differences in progressive glucose intolerance and hip geometry: the Baltimore Longitudinal Study of Aging |
Q61453667 | Short-Term Outcomes of Interdisciplinary Hip Fracture Rehabilitation in Frail Elderly Inpatients |
Q37469982 | Social support for exercise by experts in older women post-hip fracture |
Q36954913 | Stability and Change in Activities of Daily Living Among Older Mexican Americans |
Q35627029 | Tamoxifen use reduces the risk of osteoporotic fractures in women with breast cancer in Asia: a nationwide population-based cohort study. |
Q36683942 | The 1-year mortality of patients treated in a hip fracture program for elders |
Q80833944 | The 24-h distribution of falls and person-hours of physical activity in the home are strongly associated among community-dwelling older persons |
Q37856217 | The 25th anniversary of BUA for the assessment of osteoporosis: time for a new paradigm? |
Q88955809 | The American Orthopaedic Association's Own the Bone® database: a national quality improvement project for the treatment of bone health in fragility fracture patients |
Q90194817 | The Increase of Osteoporotic Hip Fractures and Associated One-Year Mortality in Poland: 2008-2015 |
Q34136768 | The Influence of Short-term Aquatic Training on Obstacle Crossing in Gait by the Elderly |
Q37432366 | The aftermath of hip fracture: discharge placement, functional status change, and mortality. |
Q37730447 | The burden of second hip fractures: provincial surgical hospitalizations over 15 years. |
Q33741164 | The development of a comprehensive multidisciplinary care pathway for patients with a hip fracture: design and results of a clinical trial |
Q33396370 | The effect of time-to-surgery on outcome in elderly patients with proximal femoral fractures |
Q40509187 | The effects of state-level expenditures for home- and community-based services on the risk of becoming a long-stay nursing home resident after hip fracture |
Q58803168 | The epidemiology and economic burden of hip fractures in Israel |
Q36569605 | The evolving role of exemestane in the management of breast cancer |
Q34590994 | The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications |
Q36006677 | The need for microsimulation to evaluate osteoporosis interventions. |
Q34251696 | The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system |
Q42839510 | The role of the nurse in the management of osteoporosis |
Q37230573 | The second hip fracture in osteoporotic patients: not only an orthopaedic matter |
Q34110560 | The synergistic effect of functional status and comorbidity burden on mortality: a 16-year survival analysis. |
Q39724622 | The treatment of osteopenia in Asian women: a new approach |
Q47766890 | Thinking falls-taking action: a falls prevention tool for care homes. |
Q51183098 | Time dependency of bone density estimation from computed tomography with intravenous contrast agent administration. |
Q37768158 | Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms |
Q92188147 | Tobacco and bone fractures: A review of the facts and issues that every orthopaedic surgeon should know |
Q83706992 | Trajectories of functional change among long stayers in nursing homes: does baseline impairment matter? |
Q35229889 | Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly, 1996–2007 |
Q36580627 | Type 2 diabetes and bone fractures |
Q37639402 | Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture |
Q35719101 | Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study |
Q45091227 | Use of strontium as a treatment method for osteoporosis |
Q48050798 | Validation of the Malay version of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) in Malaysia |
Q48222095 | What determines health-related quality of life in hip fracture patients at the end of acute care?--a prospective observational study |
Q44787178 | Withholding clopidogrel for 3 to 6 versus 7 days or more before surgery in hip fracture patients |
Q82238896 | [Acute orthogeriatric care (II). Clinical aspects] |
Q50760664 | [Hip fracture incidence in an urban area in Northeast Brazil]. |
Q79197119 | [The elder patient with a rheumatic disease and comorbidities. Aspects of rheumatology in an ageing population] |
Search more.